Publicaciones en las que colabora con María Teresa Bascarán Fernández (56)

2016

  1. A review of quality-of-life assessment measures in schizophrenia: Limitations and future developments

    Beyond Assessment of Quality of Life in Schizophrenia (Springer International Publishing), pp. 65-77

  2. Treatments for Opioid Dependence and Methadone: Neurological and Behavioral Aspects

    Neuropathology of Drug Addictions and Substance Misuse (Elsevier Inc.), pp. 595-602

2015

  1. Psychometric evaluation of the negative syndrome of schizophrenia

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, Núm. 7, pp. 559-566

2014

  1. Long term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack?

    British Journal of Clinical Pharmacology, Vol. 77, Núm. 2, pp. 272-284

2013

  1. Evolución de la prevalencia administrativa de los trastornos mentales durante 13 años en Asturias (norte de España)

    Revista de Psiquiatria y Salud Mental, Vol. 6, Núm. 2, pp. 60-66

2012

  1. Functional impairment as a defining feature of: Amnestic MCI cognitive, emotional, and demographic correlates

    International Psychogeriatrics, Vol. 24, Núm. 9, pp. 1494-1504

2011

  1. A cross-cultural comparison between Spain and the USA: Temperament and character distribution by sex and age

    Psychiatry Research, Vol. 186, Núm. 2-3, pp. 397-401

  2. Disertaciones sobre psiquiatría

    Fundación Española de Psiquiatría y Salud Mental

  3. Role of serotonergic-related systems in suicidal behavior: Data from a case-control association study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Núm. 6, pp. 1518-1524

  4. Self-perceived needs are related to violent behavior among schizophrenia outpatients

    Journal of Nervous and Mental Disease, Vol. 199, Núm. 9, pp. 666-671

  5. Sixth version of the Addiction Severity Index: Assessing sensitivity to therapeutic change and retention predictors

    International journal of clinical and health psychology, Vol. 11, Núm. 3, pp. 495-508

  6. Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable

    Revista de Psiquiatria y Salud Mental, Vol. 4, Núm. 1, pp. 9-18

2010

  1. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, Núm. 1, pp. 26-31

  2. Impact of substance use on the physical health of patients with bipolar disorder

    Acta Psychiatrica Scandinavica, Vol. 121, Núm. 6, pp. 437-445

  3. Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians

    Psychiatric Genetics, Vol. 20, Núm. 4, pp. 171-178

2009

  1. Cardiovascular risk in patients with bipolar disorder

    Journal of Affective Disorders, Vol. 115, Núm. 3, pp. 302-308

  2. Differential role of serotonergic polymorphisms in alcohol and heroin dependence

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 33, Núm. 4, pp. 695-700

  3. Role of serotonergic polymorphisms in the clinical severity of the panic disorder

    Revista de Psiquiatria y Salud Mental, Vol. 2, Núm. 1, pp. 35-41

2008

  1. Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts

    Psychiatric Genetics, Vol. 18, Núm. 5, pp. 213-218

  2. Association study between obsessive-compulsive disorder and serotonergic candidate genes

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 3, pp. 765-770